The Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale: psychometric assessment in women treated for cancer
- PMID: 31273504
- DOI: 10.1007/s00520-019-04963-2
The Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale: psychometric assessment in women treated for cancer
Abstract
Purpose: The purpose of this study was to conduct a preliminary validation of the psychometric performance of the newly developed Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale in a sample of women treated for cancer.
Methods: Partnered women (n = 250) who had received treatment for cancer completed an online survey that included the SECSI scale and measures of health-related quality of life, depression, anxiety, sexual function, sexual distress, self-efficacy for sexual functioning, sexual behaviors, relationship satisfaction, and satisfaction with sexual communication. Sociodemographic and clinical cancer characteristics data were collected.
Results: High internal consistency and strong test-retest reliability of the SECSI scale were shown with a Cronbach's alpha coefficient of 0.94 and test-retest reliability of r = 0.82, respectively. Construct validity of the SECSI scale, including discriminant, convergent, and divergent validity, was supported except regarding hypothesized relationships between SECSI scores and participant age and time since treatment.
Conclusions: The SECSI scale is a valid, reliable measure for use with partnered women treated for cancer. Clinicians working with cancer survivors who may be at risk for difficulties communicating about sex and intimacy needs after cancer treatment may use this scale to identify women who would benefit from interventions to increase their confidence to communicate with their partner. The SECSI scale fills an important gap in ability to assess self-efficacy to communicate about sex and intimacy.
Keywords: Cancer; Intimacy; Partner communication; Self-efficacy; Sexual function.
Similar articles
-
Development of the Partner Version of the Self-Efficacy to Communicate about Sex and Intimacy (SECSI-PV) Scale in the Context of Cancer Survivorship.J Psychosoc Oncol. 2025;43(3):337-355. doi: 10.1080/07347332.2024.2398095. Epub 2024 Oct 12. J Psychosoc Oncol. 2025. PMID: 39394925
-
Psychometric Evaluation of a Korean Version of the Cancer Survivors' Self-efficacy Scale.Cancer Nurs. 2019 Nov/Dec;42(6):509-514. doi: 10.1097/NCC.0000000000000691. Cancer Nurs. 2019. PMID: 30601268
-
The Development and Validation of the Sexual and Relationship Distress Scale.J Sex Med. 2018 Aug;15(8):1167-1179. doi: 10.1016/j.jsxm.2018.06.004. Epub 2018 Jul 20. J Sex Med. 2018. PMID: 30033190
-
Sexual Health Recovery For Prostate Cancer Survivors: The Proposed Role Of Acceptance And Mindfulness-Based Interventions.Sex Med Rev. 2019 Oct;7(4):627-635. doi: 10.1016/j.sxmr.2019.03.001. Epub 2019 Apr 24. Sex Med Rev. 2019. PMID: 31029619 Review.
-
Development and Content Validation of End of Treatment Questionnaires for Children With Cancer.J Pediatr Oncol Nurs. 2020 Mar/Apr;37(2):128-135. doi: 10.1177/1043454219878392. Epub 2019 Oct 9. J Pediatr Oncol Nurs. 2020. PMID: 31596172
Cited by
-
Sexual Function and the Role of Sexual Communication in Women Diagnosed with Cervical Cancer: A Systematic Review.Int J Sex Health. 2021 May 6;33(3):385-395. doi: 10.1080/19317611.2021.1919951. eCollection 2021. Int J Sex Health. 2021. PMID: 38595751 Free PMC article.
-
Sexual quality of life and sexual self-efficacy among women during reproductive-menopausal transition stages and postmenopause: a comparative study.Womens Midlife Health. 2021 Sep 17;7(1):8. doi: 10.1186/s40695-021-00067-2. Womens Midlife Health. 2021. PMID: 34535191 Free PMC article.
-
Opening the Conversation: study protocol for a Phase III trial to evaluate a couple-based intervention to reduce reproductive and sexual distress among young adult breast and gynecologic cancer survivor couples.Trials. 2022 Sep 2;23(1):730. doi: 10.1186/s13063-022-06665-3. Trials. 2022. PMID: 36056413 Free PMC article.
-
Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial.JMIR Res Protoc. 2024 Aug 19;13:e57781. doi: 10.2196/57781. JMIR Res Protoc. 2024. PMID: 39159450 Free PMC article.
-
Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study.BMJ Open. 2020 Nov 12;10(11):e038953. doi: 10.1136/bmjopen-2020-038953. BMJ Open. 2020. PMID: 33184080 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous